Inside a mouse product, offering genetic validation of CRK12:CYC9 to be a novel drug target for trypanosomiasis. Even further, functional characterisation of CRK12 and CYC9 working with RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively. As well as in vivo antileishmanial efficacy of a mix therapy https://robertl009htd3.thekatyblog.com/profile